Furthermore, recent evidence suggests that the occurrence of anti-CTLA-4 induced hypophysitis may be independent of the dose (10 versus 3 mg/kg) and the number of treatment cycles [2,13,14]. Here, CTLA4 is linked to hypophysitis.